Pfizer Inc. is an American pharmaceutical company that made international headlines in 2020 for developing a COVID-19 mRNA vaccine that would reach the world.
Founded by German immigrants and headquartered in New York, Pfizer produces and also develops a variety of medicines. Pfizer's CEO is Albert Bourla, a Sephardic Jew.
On December 27, 2020, thousands of Pfizer vaccines arrived in Israel, kicking off the country's vaccination campaign.
Some 27,167 people tested positive for COVID-19 on Saturday, and serious cases rose from 387 to 436.
Governments around the world are scrambling to buy Paxlovid, while Merck's Molnupiravir has faced setbacks after disappointing trial data.
The CEOs of Pfizer and Moderna say they are preparing a booster targeting Omicron. Pfizer CEO Albert Bourla is still unsure if there is a need for the fourth booster.
Receiving the COVID-19 vaccine lengthens the menstrual cycle - not bleeding - by less than a day, though it seems to be temporary, is considered a normal variation and is not dangerous.
Maccabi Health Services reported that most children did not have symptoms after the shots. No myocarditis cases registered.
Whatever the reasons, it’s clear that the number of people who will be trudging back to get their fourth shot will be lower than those that got their third, which was lower than the first two.
The FDA said it reviewed published data and real-world evidence on the safety of booster doses provided by the Israeli Ministry of Health.
The Pfizer vaccine against COVID-19 was the first to see proper usage in the pandemic and remains a reliable vaccine of choice in many parts of the world, including Israel.
The CDC reported that children were experiencing systemic side effects like fatigue and headache and only very few suffered from myocarditis.